HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Lazzarino Selected Research

Pipobroman (Vercyte)

2/2005Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
8/2004Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.
9/2003Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman.
3/2002Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Lazzarino Research Topics

Disease

17Multiple Myeloma
04/2010 - 10/2002
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2012 - 04/2003
5Lymphoma (Lymphomas)
05/2009 - 01/2004
5Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2005 - 04/2003
4Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2012 - 04/2003
4Leukemia
11/2008 - 01/2004
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2006 - 02/2002
3Primary Myelofibrosis (Myelosclerosis)
01/2011 - 09/2004
3Essential Thrombocythemia
11/2008 - 09/2003
3Neoplasms (Cancer)
12/2005 - 03/2004
3Cytopenia
09/2005 - 01/2003
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2005 - 02/2002
3Paraproteinemias (Monoclonal Gammopathy)
03/2005 - 04/2003
3Lymphocytosis
03/2005 - 04/2003
3Thrombosis (Thrombus)
09/2003 - 03/2002
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2012 - 04/2003
2Anemia
10/2011 - 10/2009
2Acute Promyelocytic Leukemia
05/2011 - 11/2002
2Neuralgia (Stump Neuralgia)
06/2010 - 04/2010
2Peripheral Nervous System Diseases (PNS Diseases)
04/2010 - 11/2008
2Neutropenia
07/2008 - 05/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2008 - 05/2006
2Infections
07/2008 - 01/2005
2Myeloproliferative Disorders (Myeloproliferative Disorder)
11/2006 - 09/2004
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2006 - 09/2002
2Residual Neoplasm
10/2005 - 02/2002
2Immunoglobulin Light-chain Amyloidosis
03/2005 - 04/2003
2Proteinuria
03/2005 - 04/2003
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
05/2012
1T-Cell Lymphoma (Lymphoma, T Cell)
05/2012
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
05/2012
1Death (Near-Death Experience)
10/2011
1Thrombocytopenia (Thrombopenia)
10/2009
1Leukocytosis (Pleocytosis)
10/2009
1Inflammation (Inflammations)
11/2008
1Epstein-Barr Virus Infections
11/2008
1Back Pain (Backache)
05/2008
1Vasculitis (Vasculitides)
12/2007
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2007
1Herpes Zoster
04/2007
1Hodgkin Disease (Hodgkin's Disease)
11/2006
1Hematologic Diseases (Blood Diseases)
04/2006
1Bronchiolitis Obliterans Syndrome
04/2006
1Nephrotic Syndrome (Syndrome, Nephrotic)
04/2006
1Pneumonia (Pneumonitis)
04/2006
1Febrile Neutropenia
04/2006
1Agammaglobulinemia (Hypogammaglobulinemia)
04/2006

Drug/Important Bio-Agent (IBA)

9Bortezomib (Velcade)FDA Link
06/2010 - 04/2007
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2012 - 10/2002
6Rituximab (Mabthera)FDA Link
01/2012 - 02/2002
5Hemoglobins (Hemoglobin)IBA
10/2011 - 04/2003
4Pipobroman (Vercyte)FDA Link
02/2005 - 03/2002
3fludarabineIBA
01/2012 - 08/2007
3Dexamethasone (Maxidex)FDA LinkGeneric
02/2010 - 10/2002
3SteroidsIBA
08/2007 - 03/2005
3Imatinib Mesylate (Gleevec)FDA Link
10/2005 - 02/2002
3Immunoglobulin M (IgM)IBA
03/2005 - 04/2003
2Alemtuzumab (Campath)FDA Link
05/2012 - 11/2008
2Dihydrotachysterol (AT 10)IBA
11/2008 - 01/2003
2Filgrastim (Neupogen)FDA Link
07/2008 - 05/2008
2pegfilgrastim (Neulasta)FDA Link
07/2008 - 04/2006
2Biological ProductsIBA
11/2006 - 01/2004
2Immunoglobulins (Immunoglobulin)IBA
10/2006 - 03/2005
2Hydroxyurea (Hydrea)FDA LinkGeneric
02/2006 - 09/2003
2Zoledronic Acid (Zometa)FDA Link
07/2005 - 06/2005
2Vincristine (Oncovin)FDA LinkGeneric
01/2005 - 03/2004
2Messenger RNA (mRNA)IBA
09/2004 - 03/2002
1Arsenic Trioxide (Trisenox)FDA Link
05/2011
1Interleukin-6 (Interleukin 6)IBA
06/2010
1Proteasome InhibitorsIBA
04/2010
1Thalidomide (Thalomid)FDA Link
09/2009
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2009
1fotemustine (Muphoran)IBA
03/2009
1Pharmaceutical PreparationsIBA
11/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2008
1Analgesics (Analgesic Drugs)IBA
05/2008
1Dacarbazine (DIC)FDA LinkGeneric
11/2006
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2006
1Janus Kinase 2IBA
11/2006
1Vinblastine (Vinblastine Sulfate)FDA Link
11/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2006
1Core Binding Factors (Core-Binding Factor)IBA
05/2006
1Codon (Codons)IBA
05/2006
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2006
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
04/2006

Therapy/Procedure

9Therapeutics
05/2012 - 11/2002
9Drug Therapy (Chemotherapy)
07/2008 - 11/2002
3Splenectomy
05/2007 - 01/2003
2Transplantation
02/2010 - 09/2004
2Radiotherapy
11/2006 - 09/2005
2Hematopoietic Stem Cell Transplantation
04/2006 - 01/2004
2Stem Cell Transplantation
04/2006 - 01/2004
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2006 - 09/2005
2Combination Drug Therapy (Combination Chemotherapy)
03/2005 - 01/2005
1Erythrocyte Transfusion
01/2011
1Consolidation Chemotherapy
07/2008
1Hematopoietic Stem Cell Mobilization
05/2008
1Drug Tapering
11/2006
1Adjuvant Radiotherapy
11/2006